Your browser doesn't support javascript.
loading
miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
Zou, Zhenyou; Zou, Ruyi; Zong, Dan; Shi, Yonghong; Chen, Jinyao; Huang, Jie; Zhu, Jiahui; Chen, Liguan; Bao, Xiaoyan; Liu, Yuan; Liu, Weihao; Huang, Wenhui; Hu, Jingsang; Chen, Zhi; Lao, Xiaojie; Chen, Chaoqun; Huang, Xiaoli; Lu, Yao; Ni, Xueyin; Fang, Daoquan; Wu, Dengqiang; Lu, Shuangshuang; Jiang, Mingzhu; Qiu, Chenyang; Wu, Yuya; Qiu, Qisha; Dong, Yanyuan; Su, Yangyang; Zhao, Chenmin; Zhong, Zhihe; Cai, Jing; Liang, Yong.
Affiliation
  • Zou Z; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Zou R; Biochemistry Department of Purdue University, West Lafayette, IN, USA.
  • Zong D; Chemistry Department of Shangrao Normal University, Shangrao, JX, China.
  • Shi Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Chen J; Life science College of Nanjing Agricultural University, Nanjing, JS, China.
  • Huang J; Radiology Department of Taizhou Hospital, Taizhou, ZJ, China.
  • Zhu J; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Chen L; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Bao X; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Liu Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Liu W; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Huang W; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Hu J; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Chen Z; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Lao X; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Chen C; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Huang X; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Lu Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Ni X; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Fang D; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Wu D; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Lu S; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Jiang M; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Qiu C; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Wu Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Qiu Q; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Dong Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Su Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Zhao C; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Zhong Z; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Cai J; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
  • Liang Y; Tumor Institute, Taizhou University, Taizhou, ZJ, China.
J Cell Mol Med ; 21(9): 1929-1943, 2017 09.
Article in En | MEDLINE | ID: mdl-28411377
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Paclitaxel / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Drug Resistance, Multiple / Drug Resistance, Neoplasm / MicroRNAs Limits: Animals / Humans Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2017 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Paclitaxel / ATP Binding Cassette Transporter, Subfamily B, Member 1 / Drug Resistance, Multiple / Drug Resistance, Neoplasm / MicroRNAs Limits: Animals / Humans Language: En Journal: J Cell Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2017 Type: Article Affiliation country: China